A - Human Necessities – 61 – G
Patent
A - Human Necessities
61
G
A61G 99/00 (2006.01) G06F 19/00 (2011.01)
Patent
CA 2401913
A method, apparatus and system for use in treating a patient receiving an antineoplastic drug to optimize therapy and prevent an adverse drug response. This system employs surrogate markers or indicators including blood levels of the antineoplastic drug to determine the next required dose for a patient. Since the surrogate markers are employed as a percent change in status, virtually any indicator can be used. Surrogate markers could include any measure of the effectiveness of the antineoplastic drug's action. Given the effectiveness of the antineoplastic drug's action relative to the surrogate markers, a change in antineoplastic drug dose is calculated by the system. Conversely, by employing this system, one could determine the expected result of the antineoplastic drug dose change on the surrogate markers.
Kutzko John D.
Mcmichael John P.
Singer Michaeal G.
Dimensional Dosing Systems Incorporated
Ridout & Maybee Llp
The Rxfiles Corporation
LandOfFree
Method, apparatus and system for use in treating patient... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method, apparatus and system for use in treating patient..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method, apparatus and system for use in treating patient... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1785307